Covid-19: Sputnik V will now get Dose soon After Approval, 85 Million Doses will be Made in India in a Year

Sputnik V will now get Dose soon After Approval

Among the five pharmaceutical companies with which RDIF is making a large number of vaccines in India are Gland Pharma Hetero Biopharma Panacea Biotech Stellis Biopharma Virchow Biotech. The objective is to produce more than 850 million doses per year.

New Delhi: Russian-made Covid vaccine Sputnik V has been approved in India. At the same time, according to the news, Sputnik V vaccine will be made by five pharma companies in the country and 850 million (85 crores) dose is going to be produced annually. Apart from this, it is being told that by the end of April India can get the dose of this vaccine.

The Russian vaccine was approved after being approved by a special committee of the Drug Controller General of India (DCGI), India’s drug regulator. The Subject Expert Committee of the Central Drugs Standard Control Organization approved it after the deadly second wave in the country on Monday. Let me tell you that there is a lot of ruckus in many states about the lack of vaccines.

Also Read: Important Tips: छात्र कठिन विषयों से कैसे निपटते हैं ? मोदी द्वारा सुनाए गए मंत्र…

Sputnik V manufactured in India by Dr. Reddy’s is effective up to 91.6 percent. The drug regulator Drug Controller General of India gave the green signal only after Sputnik-V was found to be completely safe and effective in preventing infection. It was reported that this is the highest effect after Modern and Pfizer. At the same time, the vaccine is already in the third phase of the clinical trial in India and Dr. Reddy applied in February to approve the emergency use of the vaccine. Explain that the most effective vaccine so far has been approved in 59 countries. Now India is the 60th country.

In a statement, Russia’s RDIF (Russian Direct Investment Fund) said that India is the most populous country where the Russian vaccine has been approved. A total population of 60 countries where Sputnik V has been approved for use, comprising 3 billion people or about 40 percent of the global population.

Among the five pharmaceutical companies with which RDIF is going to make a large number of vaccines in India are Gland Pharma, Hetero Biopharma, Panacea Biotech, Stellis Biopharma, Virchow Biotech. The objective is to produce more than 850 million doses per year. Let us know that in the country, currently being vaccinated with AstraZeneca’s Kovishield and Bharat Biotech’s Kovaxin. The Russian vaccine Sputnik is said to be more effective than the two.

For More Updates and Latest Hindi News Like us on Facebook and Follow on Twitter.